Study of Pomalidomide in Anal Cancer Precursors (SPACE): a Phase 2 Study of Immunomodulation in People With Persistent HPV-associated High Grade Squamous Intraepithelial Lesions
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2019
Price : $35 *
At a glance
- Drugs Pomalidomide (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- Acronyms SPACE
- 21 Aug 2019 Planned End Date changed from 1 Mar 2022 to 1 Sep 2021.
- 06 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Jun 2017 Status changed from not yet recruiting to recruiting.